Effect of ramipril on the incidence of diabetes.
BACKGROUND: Previous studies have suggested that blockade of the renin-angiotensin system may prevent diabetes in people with cardiovascular disease or hypertension. METHODS: In a double-blind, randomized clinical trial with a 2-by-2 factorial design, we randomly assigned 5269 participants without...
Auteurs principaux: | Bosch, J, Yusuf, S, Gerstein, H, Pogue, J, Sheridan, P, Dagenais, G, Diaz, R, Avezum, A, Lanas, F, Probstfield, J, Fodor, G, Holman, R |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2006
|
Documents similaires
-
Incidence of diabetes following ramipril or rosiglitazone withdrawal
par: Holman, R, et autres
Publié: (2011) -
Incidence of diabetes following ramipril or rosiglitazone withdrawal.
par: Investigators, D
Publié: (2011) -
Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.
par: Punthakee, Z, et autres
Publié: (2012) -
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
par: Gerstein, H, et autres
Publié: (2006) -
A Comparative Evaluation of Ramipril as Monotherapy and Combination of Ramipril with Torsemide in Hypertension
par: Navjot Kaur, et autres
Publié: (2017-11-01)